These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23051650)

  • 1. Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions.
    Maldi E; Travelli C; Caldarelli A; Agazzone N; Cintura S; Galli U; Scatolini M; Ostano P; Miglino B; Chiorino G; Boldorini R; Genazzani AA
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):144-6. PubMed ID: 23051650
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase.
    Zhang LY; Liu LY; Qie LL; Ling KN; Xu LH; Wang F; Fang SH; Lu YB; Hu H; Wei EQ; Zhang WP
    Eur J Pharmacol; 2012 Jan; 674(2-3):163-70. PubMed ID: 22119381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Key role of nicotinamide phosphoribosyltransferase (NAMPT) and NAD metabolism in the transition of melanoma cells to an invasive and drug-resistant phenotype].
    Bertolotto C; Ohanna M; Ballotti R
    Med Sci (Paris); 2018 Dec; 34(12):1025-1028. PubMed ID: 30623759
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil.
    Bi TQ; Che XM; Liao XH; Zhang DJ; Long HL; Li HJ; Zhao W
    Oncol Rep; 2011 Nov; 26(5):1251-7. PubMed ID: 21743967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells.
    Grozio A; Sociali G; Sturla L; Caffa I; Soncini D; Salis A; Raffaelli N; De Flora A; Nencioni A; Bruzzone S
    J Biol Chem; 2013 Sep; 288(36):25938-25949. PubMed ID: 23880765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase.
    Olesen UH; Petersen JG; Garten A; Kiess W; Yoshino J; Imai S; Christensen MK; Fristrup P; Thougaard AV; Björkling F; Jensen PB; Nielsen SJ; Sehested M
    BMC Cancer; 2010 Dec; 10():677. PubMed ID: 21144000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma.
    Grolla AA; Torretta S; Gnemmi I; Amoruso A; Orsomando G; Gatti M; Caldarelli A; Lim D; Penengo L; Brunelleschi S; Genazzani AA; Travelli C
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):718-29. PubMed ID: 26358657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils.
    Pylaeva E; Harati MD; Spyra I; Bordbari S; Strachan S; Thakur BK; Höing B; Franklin C; Skokowa J; Welte K; Schadendorf D; Bankfalvi A; Brandau S; Lang S; Jablonska J
    Int J Cancer; 2019 Jan; 144(1):136-149. PubMed ID: 30121947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.
    Tan B; Young DA; Lu ZH; Wang T; Meier TI; Shepard RL; Roth K; Zhai Y; Huss K; Kuo MS; Gillig J; Parthasarathy S; Burkholder TP; Smith MC; Geeganage S; Zhao G
    J Biol Chem; 2013 Feb; 288(5):3500-11. PubMed ID: 23239881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer.
    Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL
    J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based discovery of a potent NAMPT inhibitor.
    Korepanova A; Longenecker KL; Pratt SD; Panchal SC; Clark RF; Lake M; Gopalakrishnan SM; Raich D; Sun C; Petros AM
    Bioorg Med Chem Lett; 2018 Feb; 28(3):437-440. PubMed ID: 29287958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NAMPT pathway by FK866 activates the function of p53 in HEK293T cells.
    Thakur BK; Dittrich T; Chandra P; Becker A; Lippka Y; Selvakumar D; Klusmann JH; Reinhardt D; Welte K
    Biochem Biophys Res Commun; 2012 Aug; 424(3):371-7. PubMed ID: 22728882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide phosphoribosyltransferase inhibitor APO866 induces C6 glioblastoma cell death via autophagy.
    Yang P; Zhang L; Shi QJ; Lu YB; Wu M; Wei EQ; Zhang WP
    Pharmazie; 2015 Oct; 70(10):650-5. PubMed ID: 26601421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.
    Ohanna M; Cerezo M; Nottet N; Bille K; Didier R; Beranger G; Mograbi B; Rocchi S; Yvan-Charvet L; Ballotti R; Bertolotto C
    Genes Dev; 2018 Mar; 32(5-6):448-461. PubMed ID: 29567766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes.
    Schilling E; Wehrhahn J; Klein C; Raulien N; Ceglarek U; Hauschildt S
    Innate Immun; 2012 Jun; 18(3):518-30. PubMed ID: 21975728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells.
    Ogino Y; Sato A; Uchiumi F; Tanuma SI
    Genomics; 2019 Dec; 111(6):1889-1895. PubMed ID: 30582964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells.
    Nagaya M; Hara H; Kamiya T; Adachi T
    Arch Biochem Biophys; 2019 Nov; 676():108155. PubMed ID: 31628926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte Differentiation Promotes Cell Survival During Nicotinamide Phosphoribosyltransferase Inhibition Through Increased Maintenance of Cellular Energy Stores.
    Kropp EM; Broniowska KA; Waas M; Nycz A; Corbett JA; Gundry RL
    Stem Cells Transl Med; 2017 Apr; 6(4):1191-1201. PubMed ID: 28224719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide phosphoribosyltransferase production in human spermatozoa is influenced by maturation stage.
    Riammer S; Garten A; Schaab M; Grunewald S; Kiess W; Kratzsch J; Paasch U
    Andrology; 2016 Nov; 4(6):1045-1053. PubMed ID: 27566659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression.
    Sauer H; Kampmann H; Khosravi F; Sharifpanah F; Wartenberg M
    Clin Exp Pharmacol Physiol; 2021 Mar; 48(3):422-434. PubMed ID: 33349973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.